New Cancer Pill Found More Effective Against Leukemia Than Chemo, Study Shows Medicine & Technology Dec 08, 2015 A cancer drug by Johnson & Johnson and AbbVie called Imbruvica can significantly decrease risk of death and slow down disease advancement with an estimated 84 percent lowered risk.
Pharmacyclics May Soon Be Acquired by Johnson & Johnson for $18 Billion Mar 03, 2015 Pharmacyclics will ‘possibly’ be acquired by Johnson & Johnson for $18 Billion
Sunscreen Myths Debunked; Expert Warns Against 'Dangerous' Sun Protection Ideas That Only Puts One at Added Risk